Ostatní
Návod 
Alkermes plc
ALKS
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
5.4B
Obrat
1B
Zisk
0B
Aktiva
2B
Dluh
0B
ROE
20%
ROA
15%
PE
20
PS
3
Cena 1R
25-36
⌀ Cena
29.30
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
29-04-2026
Poslední dividenda
Profil
Alkermes plc, biofarmaceutická společnost, zkoumá, vyvíjí a komercializuje farmaceutické výrobky pro řešení nenaplněných lékařských potřeb pacientů v různých terapeutických oblastech ve Spojených státech, Irsku a mezinárodně. Mezi výrobky uváděné na trh patří ARISTADA, intramuskulární injekční suspenze pro léčbu schizofrenie; VIVITROL pro léčbu alkoholu a prevenci závislosti na opioidech; RISPERDAL CONSTA pro léčbu schizofrenie a bipolární poruchy I; INVEGA SUSTENNA pro léčbu schizofrenie a schizoafektivní poruchy; XEPLION, INVEGA TRINZA a TREVICTA pro léčbu schizofrenie a schizoafektivních poruch; a VUMERITY pro léčbu relabujících forem roztroušené sklerózy u dospělých, včetně klinicky izolovaných syndromů relaps-remitentní a aktivní sekundárně progresivní onemocnění. Společnost také vyvíjí přípravek LYBALVI, perorální atypický kandidát na antipsychotické léčivo pro léčbu dospělých se schizofrenií a bipolární poruchou typu I, a nemvaleukin alfa, umělý fúzní protein, který rozšiřuje imunitní buňky ničící nádory a zabraňuje aktivaci imunosupresivních buněk. Spolupracuje především s firmami Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc a Janssen Pharmaceutica International. Společnost Alkermes plc byla založena v roce 1987 a sídlí v irském Dublinu.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
1800
Založení
1991-07-16
Podobné společnosti
$ 70.79
- $ 1.00
$ 87.47
+ $ 0.92
$ 81.40
+ $ 1.86
$ 22.42
- $ 0.15
$ 30.13
- $ 2.12
$ 40.77
+ $ 1.54
$ 42.05
+ $ 0.40
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 1,475.9 | 1,475.9 | 1,557.6 | 1,663.4 | 1,111.8 | 1,173.8 | 1,038.8 | 1,170.9 | 1,094.3 | 903.4 | 745.7 | 628.3 | 618.8 | 575.5 | 390.0 | 186.6 | 178.3 | |
| Cost of Revenues | 202.1 | 202.1 | 245.3 | 288.7 | 218.1 | 603.9 | 572.9 | 693.2 | 601.8 | 567.6 | 519.3 | 483.4 | 447.9 | 310.5 | 127.6 | 52.2 | 49.4 | |
| Gross Profit | 1,273.8 | 1,273.8 | 1,312.3 | 1,374.7 | 893.7 | 569.8 | 465.9 | 477.7 | 492.4 | 335.7 | 226.4 | 144.9 | 170.9 | 265.1 | 262.4 | 134.5 | 128.8 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 384.5 | 394.2 | 390.7 | 306.5 | 430.0 | 378.1 | 399.1 | 350.4 | 377.5 | 380.9 | |
| Cost of Revenues | 51.8 | 51.6 | 49.5 | 49.2 | 62.1 | 63.1 | 61.5 | 58.6 | 79.1 | 61.5 | |
| Gross Profit | 332.7 | 342.6 | 341.2 | 257.3 | 367.9 | 315.0 | 337.7 | 291.7 | 298.4 | 319.4 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 270.8 | 393.8 | 1.0 | 1.9 | 52.8 | 68.9 | 7.2 | 2.3 | 4.0 | 7.8 | 6.5 | 141.9 | 97.2 | 95.4 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 689.8 | 605.7 | 561.0 | 538.8 | 599.4 | 526.4 | 421.6 | 374.1 | 311.6 | 199.9 | 125.8 | 137.6 | 82.8 | 76.5 | |
| Depreciation & Amortization | 27.2 | 27.2 | 28.5 | 74.9 | 46.1 | 38.1 | 60.1 | 55.2 | 72.4 | 62.1 | 61.0 | 57.7 | 58.2 | 73.8 | 93.7 | 8.7 | 25.0 | |
| Total Operating Expenses | 1,019.9 | 1,019.9 | 891.7 | 996.2 | 1,036.0 | 599.1 | 578.3 | 639.8 | 591.6 | 483.6 | 435.1 | 369.2 | 258.1 | 167.6 | 350.7 | 180.1 | 171.9 | |
| Operating Income | 254.0 | 254.0 | 420.6 | 414.1 | -142.3 | -26.7 | -112.4 | -162.1 | -99.1 | -147.9 | -208.7 | -224.3 | -87.1 | 81.8 | -88.3 | -45.6 | -43.0 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 73.9 | 97.1 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 169.8 | 169.4 | ||
| Depreciation & Amortization | 3.8 | 8.1 | 7.8 | 7.4 | 6.8 | 7.0 | 6.7 | 8.1 | 18.2 | 18.7 | ||
| Total Operating Expenses | 274.6 | 253.5 | 248.2 | 243.5 | 205.2 | 210.3 | 227.8 | 248.4 | 243.7 | 275.6 | ||
| Operating Income | 58.1 | 89.1 | 93.0 | 13.8 | 162.7 | 104.8 | 109.9 | 43.3 | 54.6 | 43.8 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 45.3 | 45.3 | 42.5 | 30.9 | 7.6 | 2.4 | 7.0 | 14.0 | 9.2 | 4.6 | 3.8 | 3.3 | 2.0 | 0.8 | 1.5 | 2.7 | 4.7 | |
| Interest Expense | 12.3 | 12.3 | 22.6 | 23.0 | 13.0 | 11.2 | 8.7 | 13.6 | 15.4 | 12.0 | 14.9 | 13.2 | 13.4 | 49.0 | 28.1 | 3.3 | 6.0 | |
| Other Expense | 37.5 | 37.5 | 23.1 | 7.4 | -25.0 | -12.6 | 15.9 | -35.0 | -27.8 | 12.0 | 5.4 | 10.2 | 84.6 | -13.9 | 0.5 | -0.3 | -0.4 | |
| IBT | 291.5 | 291.5 | 443.8 | 421.5 | -167.3 | -39.3 | -96.5 | -197.1 | -127.0 | -143.3 | -214.4 | -224.0 | -14.0 | 35.4 | -114.4 | -46.5 | -44.7 | |
| Income Tax Expense | 49.8 | 49.8 | 71.6 | -97.6 | -9.0 | 8.9 | 14.3 | -0.4 | 12.3 | 14.7 | -5.9 | 3.2 | 16.0 | 10.5 | -0.7 | -1.0 | -5.1 | |
| Net Income | 241.7 | 241.7 | 367.1 | 355.8 | -158.3 | -48.2 | -110.9 | -196.6 | -139.3 | -157.9 | -208.4 | -227.2 | -30.1 | 25.0 | -113.7 | -45.5 | -39.6 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 12.1 | 11.9 | 11.1 | 10.1 | 11.4 | 10.9 | 10.7 | 9.4 | 9.7 | 9.4 | ||
| Interest Expense | 12.3 | 0.0 | 0.0 | 0.0 | 4.6 | 6.0 | 6.0 | 6.0 | 6.1 | 6.0 | ||
| Other Expense | 2.3 | 11.7 | 11.9 | 11.7 | 7.2 | 5.5 | 6.8 | 3.6 | 3.7 | 3.5 | ||
| IBT | 60.4 | 100.7 | 104.8 | 25.5 | 169.9 | 110.2 | 116.7 | 46.9 | 58.3 | 47.4 | ||
| Income Tax Expense | 11.0 | 18.0 | 17.7 | 3.0 | 24.2 | 17.4 | 22.1 | 8.0 | -102.2 | -0.4 | ||
| Net Income | 49.3 | 82.8 | 87.1 | 22.5 | 146.5 | 92.4 | 91.4 | 36.8 | 112.8 | 47.8 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $2.14 | $-0.97 | $-0.30 | $-0.70 | $-1.25 | $-0.90 | $-1.03 | $-1.38 | $-1.52 | $-0.21 | $0.19 | $-0.99 | $-0.48 | $-0.42 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $2.10 | $-0.97 | $-0.30 | $-0.70 | $-1.25 | $-0.90 | $-1.03 | $-1.38 | $-1.52 | $-0.21 | $0.18 | $-0.99 | $-0.48 | $-0.42 | |
| Shares Outstanding | 164.7 | 164.7 | 165.4 | 166.2 | 163.5 | 160.9 | 158.8 | 157.1 | 155.1 | 153.4 | 151.5 | 149.2 | 145.3 | 131.7 | 114.7 | 95.6 | 94.8 | |
| Diluted Shares Outstanding | 168.7 | 168.7 | 169.2 | 169.7 | 163.5 | 160.9 | 158.8 | 157.1 | 155.1 | 153.4 | 151.5 | 149.2 | 145.3 | 137.1 | 114.7 | 95.6 | 94.8 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.68 | $0.29 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.66 | $0.28 | ||
| Shares Outstanding | 164.7 | 165.1 | 165.0 | 163.4 | 162.0 | 163.4 | 168.3 | 168.0 | 166.9 | 166.6 | ||
| Diluted Shares Outstanding | 168.7 | 168.5 | 168.4 | 168.7 | 166.6 | 167.0 | 171.0 | 173.0 | 170.1 | 171.9 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 535.2 | 291.1 | 457.5 | 292.5 | 337.5 | 273.0 | 203.8 | 266.8 | 191.3 | 186.4 | 181.1 | 224.1 | 97.0 | 83.6 | 38.4 | 79.3 | |
| Short Term Investments | 341.0 | 460.5 | 316.0 | 316.0 | 198.8 | 362.1 | 331.2 | 272.5 | 242.2 | 310.9 | 353.7 | 407.1 | 124.4 | 106.8 | 162.9 | 202.1 | |
| Total Cash & ST Investments | 876.1 | 751.7 | 773.5 | 740.1 | 765.7 | 659.8 | 614.4 | 620.0 | 590.7 | 619.2 | 798.8 | 801.6 | 221.4 | 190.4 | 201.3 | 281.4 | |
| Accounts Receivable | 369.9 | 389.5 | 333.2 | 296.9 | 326.6 | 289.5 | 265.5 | 300.5 | 233.6 | 191.1 | 155.5 | 151.6 | 124.6 | 96.4 | 23.0 | 25.3 | |
| Inventory | 194.7 | 182.9 | 186.4 | 181.4 | 150.3 | 125.7 | 101.8 | 90.2 | 93.3 | 63.0 | 38.4 | 51.4 | 43.5 | 39.8 | 20.4 | 20.7 | |
| Other Current Assets | 101.4 | 91.3 | 192.4 | 43.5 | 49.0 | 60.7 | 59.7 | 53.3 | 48.5 | 39.3 | 26.3 | 42.7 | 19.1 | 12.6 | 294.7 | 350.2 | |
| Total Current Assets | 1,542.2 | 1,415.4 | 1,485.5 | 1,261.9 | 1,291.6 | 1,135.8 | 1,041.4 | 1,064.0 | 966.1 | 912.6 | 1,019.0 | 1,047.3 | 408.6 | 339.2 | 346.4 | 407.1 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 616.4 | 521.2 | 399.8 | 291.1 | 396.3 | 535.2 | 420.8 | 457.5 | 647.7 | 665.8 | |
| Short Term Investments | 0.0 | 494.5 | 0.0 | 460.5 | 512.6 | 341.0 | 324.3 | 316.0 | 241.4 | 163.3 | |
| Total Cash & ST Investments | 616.4 | 1,015.7 | 399.8 | 751.7 | 908.9 | 876.1 | 745.0 | 813.4 | 995.6 | 907.2 | |
| Accounts Receivable | 355.1 | 354.9 | 318.7 | 389.5 | 370.2 | 369.9 | 317.1 | 333.2 | 340.5 | 334.5 | |
| Inventory | 191.0 | 191.9 | 183.4 | 182.9 | 191.1 | 194.7 | 198.4 | 186.4 | 192.2 | 189.4 | |
| Other Current Assets | 579.8 | 72.7 | 577.1 | 91.3 | 94.0 | 101.4 | 208.3 | 192.4 | 43.0 | 44.5 | |
| Total Current Assets | 1,741.7 | 1,635.3 | 1,479.1 | 1,415.4 | 1,564.2 | 1,542.2 | 1,468.8 | 1,431.1 | 1,571.2 | 1,475.5 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 310.6 | 311.8 | 318.4 | 325.4 | 341.1 | 350.0 | 362.2 | 310.0 | 284.7 | 264.8 | 254.8 | 265.7 | 288.4 | 303.0 | 95.0 | 96.9 | |
| Goodwill | 83.0 | 83.0 | 83.0 | 92.9 | 92.9 | 92.9 | 92.9 | 92.9 | 92.9 | 92.9 | 92.9 | 94.2 | 92.7 | 92.7 | 0.0 | 0.0 | |
| Intangible Assets | 0.9 | 0.9 | 2.0 | 37.7 | 74.0 | 111.2 | 150.6 | 191.0 | 256.2 | 318.2 | 379.2 | 479.4 | 576.0 | 617.8 | 0.0 | 0.0 | |
| Long-Term Investments | 86.4 | 73.1 | 39.9 | 131.6 | 229.4 | 24.8 | 79.4 | 80.7 | 157.2 | 121.9 | 264.1 | 170.5 | 82.8 | 55.7 | 93.4 | 68.8 | |
| Other Long-Term Assets | 16.3 | 16.5 | 11.5 | -1.1 | -86.3 | 148.9 | -17.6 | 0.6 | -58.4 | -31.8 | -195.1 | -149.3 | 21.7 | 26.8 | -82.3 | -57.2 | |
| Total Long-Term Assets | 664.7 | 640.2 | 650.7 | 702.1 | 732.9 | 814.0 | 764.0 | 761.0 | 831.2 | 813.8 | 836.7 | 874.0 | 1,061.7 | 1,096.1 | 106.1 | 108.5 | |
| Total Assets | 2,206.8 | 2,055.6 | 2,136.2 | 1,964.0 | 2,024.5 | 1,949.7 | 1,805.4 | 1,825.0 | 1,797.2 | 1,726.4 | 1,855.7 | 1,921.3 | 1,470.3 | 1,435.2 | 452.4 | 515.6 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 326.1 | 319.9 | 316.3 | 311.8 | 311.5 | 310.6 | 314.3 | 226.9 | 327.5 | 323.8 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 83.0 | 83.0 | 83.0 | 83.0 | 83.0 | 92.9 | 92.9 | |
| Intangible Assets | 83.9 | 83.9 | 83.9 | 0.9 | 0.9 | 0.9 | 0.9 | 2.0 | 11.0 | 20.0 | |
| Long-Term Investments | 27.9 | 38.3 | 32.2 | 73.1 | 18.9 | 86.4 | 62.8 | 39.9 | 106.4 | 78.1 | |
| Other Long-Term Assets | 19.7 | 19.9 | 18.4 | 16.5 | 16.8 | 16.3 | 11.5 | 157.4 | 8.0 | 43.8 | |
| Total Long-Term Assets | 587.8 | 617.5 | 602.9 | 640.2 | 591.1 | 664.7 | 655.1 | 705.1 | 708.0 | 711.7 | |
| Total Assets | 2,329.5 | 2,252.8 | 2,082.0 | 2,055.6 | 2,155.3 | 2,206.8 | 2,123.9 | 2,136.2 | 2,279.2 | 2,187.2 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 104.7 | 45.6 | 65.6 | 32.8 | 55.7 | 46.0 | 54.3 | 39.8 | 55.5 | 46.3 | 37.4 | 32.3 | 18.3 | 18.4 | 9.3 | 8.2 | |
| Short-Term Debt | 9.0 | 6.2 | 8.7 | 3.0 | 3.0 | 2.8 | 2.8 | 2.8 | 3.0 | 3.0 | 65.7 | 6.8 | 6.8 | 3.1 | -12.4 | 51.0 | |
| Other Current Liabilities | 398.5 | 412.2 | 443.1 | 455.1 | 406.2 | 381.9 | 327.2 | 294.0 | 230.6 | 160.8 | 131.3 | 88.9 | 58.6 | 60.8 | 48.1 | 29.7 | |
| Current Liabilities | 515.5 | 465.2 | 520.2 | 497.7 | 471.3 | 438.3 | 391.1 | 339.8 | 291.1 | 212.0 | 236.2 | 130.6 | 85.9 | 89.2 | 48.1 | 91.1 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 0.0 | 99.2 | 59.8 | 45.6 | 37.0 | 104.7 | 77.1 | 65.6 | 87.0 | 84.6 | |
| Short-Term Debt | 6.6 | 6.5 | 6.3 | 6.2 | 9.2 | 9.0 | 8.9 | 8.7 | 18.1 | 18.2 | |
| Other Current Liabilities | 467.7 | 400.3 | 377.6 | 412.2 | 405.2 | 398.5 | 369.7 | 417.8 | 394.7 | 381.1 | |
| Current Liabilities | 474.4 | 506.0 | 443.7 | 465.2 | 453.7 | 515.5 | 459.0 | 515.7 | 503.1 | 487.2 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 286.5 | 69.4 | 363.4 | 290.3 | 292.8 | 272.1 | 274.3 | 276.5 | 278.4 | 280.7 | 284.2 | 351.2 | 362.3 | 441.4 | 0.0 | 0.0 | |
| Capital Leases | 72.5 | 75.5 | 81.5 | 105.6 | 120.4 | 135.2 | 13.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 18.9 | 37.6 | 34.5 | 0.0 | 0.0 | |
| Total Liabilities | 922.8 | 590.6 | 933.5 | 920.2 | 911.9 | 882.7 | 720.0 | 653.7 | 594.4 | 516.9 | 541.5 | 524.4 | 517.9 | 581.4 | 60.4 | 103.0 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 65.0 | 66.2 | 67.8 | 69.4 | 356.9 | 359.0 | 361.2 | 363.4 | 366.9 | 371.3 | |
| Capital Leases | 71.6 | 72.7 | 74.1 | 75.5 | 77.2 | 72.5 | 80.0 | 81.5 | 93.6 | 97.5 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.8 | -5.0 | -5.7 | |
| Total Liabilities | 596.1 | 628.2 | 570.4 | 590.6 | 863.2 | 922.8 | 869.1 | 933.5 | 923.6 | 906.7 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | 1.3 | 1.3 | 1.1 | 1.1 | |
| Retained Earnings | -1,215.3 | -976.5 | -1,343.5 | -1,699.3 | -1,541.0 | -1,492.8 | -1,382.0 | -1,185.4 | -1,044.4 | -947.9 | -739.5 | -512.3 | -499.9 | -524.9 | -411.2 | -365.7 | |
| Comprehensive Income | -3.6 | -2.0 | -3.1 | -10.9 | -3.7 | -1.3 | -1.8 | -3.3 | -3.8 | -3.3 | -3.8 | -3.1 | -2.5 | -2.7 | -3.0 | -3.4 | |
| Total Common Equity | 1,284.0 | 1,465.0 | 1,202.7 | 1,043.8 | 1,112.6 | 1,067.0 | 1,085.4 | 1,171.3 | 1,202.8 | 1,209.5 | 1,314.3 | 1,396.8 | 952.4 | 853.9 | 392.0 | 412.6 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.7 | 1.7 | 1.7 | |
| Retained Earnings | -784.1 | -866.9 | -954.0 | -976.5 | -1,123.0 | -1,215.3 | -1,306.7 | -1,343.5 | -1,456.3 | -1,504.1 | |
| Comprehensive Income | -1.1 | -1.4 | -1.5 | -2.0 | 0.4 | -3.6 | -3.6 | -3.1 | -6.1 | -7.4 | |
| Total Common Equity | 1,733.4 | 1,624.6 | 1,511.6 | 1,465.0 | 1,292.1 | 1,284.0 | 1,254.8 | 1,202.7 | 1,355.6 | 1,280.4 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 368.0 | 75.5 | 372.2 | 293.3 | 295.8 | 275.0 | 277.1 | 279.3 | 281.4 | 283.7 | 349.9 | 358.0 | 369.0 | 444.5 | 0.0 | 51.0 | |
| Book Value | 1,284.0 | 1,465.0 | 1,202.7 | 1,043.8 | 1,112.6 | 1,067.0 | 1,085.4 | 1,171.3 | 1,202.8 | 1,209.5 | 1,314.3 | 1,396.8 | 952.4 | 853.9 | 392.0 | 412.6 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 1,733.4 | 1,624.6 | 1,511.6 | 1,465.0 | 1,292.1 | 1,284.0 | 1,254.8 | 1,202.7 | 1,355.6 | 1,280.4 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 341.9 | 241.7 | 367.1 | 355.8 | -158.3 | -48.2 | -110.9 | -196.6 | -139.3 | -157.9 | -208.4 | -227.2 | -30.1 | 25.0 | -113.7 | -45.5 | -39.6 | |
| Depreciation & Amortization | 51.6 | 27.2 | 28.5 | 74.9 | 77.9 | 78.7 | 81.9 | 80.4 | 103.7 | 98.5 | 94.3 | 85.6 | 98.1 | 73.8 | 93.7 | 8.7 | 25.0 | |
| Stock-Based Compensation | 103.1 | 0.0 | 96.6 | 100.9 | 94.3 | 87.6 | 90.2 | 101.0 | 105.4 | 83.9 | 94.4 | 97.3 | 59.6 | 34.7 | 28.8 | 19.8 | 13.9 | |
| Change Working Capital | -35.9 | 119.1 | -98.2 | -36.7 | 12.7 | -25.5 | 13.1 | 65.4 | -7.4 | -4.9 | -27.2 | 82.0 | 10.9 | -15.4 | -1.1 | 8.4 | -15.4 | |
| Change In Accounts Receivable | -34.9 | 30.2 | -56.3 | -44.5 | 25.3 | -38.0 | -18.1 | 35.1 | -58.6 | 0.0 | 0.0 | -16.5 | -17.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -21.0 | 100.9 | -58.0 | 23.0 | 15.5 | 43.3 | 59.0 | 27.2 | 46.7 | 0.0 | 0.0 | 76.2 | 56.9 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Inventories | -5.4 | -14.1 | 3.1 | -2.7 | -31.0 | -24.8 | -22.9 | -13.1 | -2.7 | -30.2 | -26.4 | 19.6 | -31.2 | -6.6 | -4.9 | 5.2 | -4.0 | |
| Other Non-cash Items | 84.6 | 104.0 | 4.5 | 6.3 | 27.3 | 4.1 | -1.4 | 22.2 | 26.4 | -7.7 | -7.1 | -40.5 | -108.1 | 10.7 | 4.3 | 1.9 | 3.7 | |
| Cash from Operations | 374.1 | 0.0 | 0.0 | 401.4 | 21.0 | 101.7 | 82.8 | 72.1 | 99.3 | 19.2 | -63.8 | -40.4 | 11.1 | 126.6 | -2.5 | -5.9 | -12.2 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 49.3 | 82.8 | 87.1 | 22.5 | 146.5 | 92.4 | 94.7 | 36.8 | 160.6 | 47.8 | |
| Depreciation & Amortization | 3.8 | 8.1 | 7.8 | 7.4 | 6.8 | 7.0 | 6.7 | 8.1 | 18.2 | 18.7 | |
| Stock-Based Compensation | -72.4 | 24.7 | 25.0 | 22.8 | 20.7 | 22.5 | 0.0 | 32.8 | 25.8 | 23.9 | |
| Change Working Capital | 91.4 | -46.4 | 30.8 | 43.3 | 6.9 | -53.5 | 14.7 | -66.3 | -2.3 | 17.9 | |
| Change In Accounts Receivable | 15.5 | 0.8 | -31.2 | 45.1 | -19.3 | 18.3 | -30.3 | -6.7 | 5.2 | -3.2 | |
| Change In Accounts Payable | 73.0 | -28.2 | 57.8 | -1.7 | 25.0 | -81.0 | 36.5 | -38.4 | -28.2 | 9.1 | |
| Change In Inventories | -4.9 | 0.8 | -8.3 | -1.8 | 9.1 | 3.5 | 3.1 | -12.6 | 7.2 | -3.0 | |
| Other Non-cash Items | 128.4 | 1.2 | 3.0 | 0.3 | 1.2 | 2.7 | 15.8 | 2.2 | -42.5 | 0.7 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 107.2 | 99.7 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -46.9 | -40.4 | -33.5 | -48.0 | -38.3 | -29.0 | -42.2 | -90.9 | -69.4 | -51.3 | -43.7 | -52.9 | -33.7 | -22.2 | -17.0 | -9.4 | -15.8 | |
| Acquisitions | 0.8 | 2.8 | 98.0 | 0.0 | 0.5 | -0.7 | 2.8 | -8.9 | 0.0 | 0.0 | -15.0 | 0.0 | 27.2 | 0.2 | -494.8 | 0.0 | -8.0 | |
| Investments | -434.1 | -364.4 | -486.5 | -254.5 | -309.7 | -340.4 | -229.5 | -277.5 | -397.7 | -431.7 | -375.1 | -508.7 | -642.5 | -303.9 | -228.5 | -370.9 | -465.4 | |
| Sales of Investment | 253.9 | 697.5 | 310.3 | 355.5 | 281.6 | 295.0 | 253.0 | 224.6 | 444.5 | 464.5 | 560.8 | 467.6 | 341.2 | 258.9 | 323.0 | 385.5 | 516.9 | |
| Other Investing Activities | -42.5 | 0.0 | 0.0 | 0.4 | 1.3 | 8.9 | 4.5 | 10.9 | 0.5 | 0.2 | 0.2 | 50.5 | 44.4 | -1.1 | 0.0 | 0.4 | 0.2 | |
| Cash from Investing | -128.4 | 0.0 | 0.0 | 53.4 | -64.5 | -66.2 | -11.5 | -141.8 | -22.2 | -18.4 | 127.2 | -43.5 | -263.4 | -68.1 | -417.2 | 5.6 | 28.0 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | -17.3 | -13.0 | -10.1 | -9.8 | -8.3 | -7.1 | -8.3 | -17.0 | -14.5 | |
| Acquisitions | 1.1 | 0.0 | 0.0 | 1.7 | 0.0 | 0.0 | 0.0 | 0.4 | 0.3 | 0.0 | |
| Investments | -55.8 | -114.7 | -97.8 | -96.0 | -89.7 | -186.9 | -95.5 | -114.5 | -67.9 | -156.3 | |
| Sales of Investment | 377.1 | 125.3 | 81.6 | 113.5 | 85.5 | 85.8 | 56.5 | 82.5 | 63.6 | 51.4 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -4.0 | -104.9 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -21.0 | -119.4 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -3.0 | 0.0 | 0.0 | -3.0 | -3.0 | -2.3 | -2.8 | -2.8 | -2.1 | -3.0 | -65.8 | -6.8 | -6.8 | -449.9 | -0.8 | -45.4 | -23.5 | |
| Debt Issued | 79.0 | 75.5 | -296.6 | 81.9 | 0.5 | 23.1 | 0.7 | 0.7 | 0.0 | 0.8 | -0.5 | -1.3 | -4.3 | 374.5 | 445.2 | -5.6 | 74.5 | |
| Issuance of Common Stock | 18.6 | 0.0 | 0.0 | 16.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 248.4 | 0.0 | 17.2 | 4.7 | 2.6 | |
| Repurchase of Common Stock | -116.9 | -31.0 | -200.3 | -28.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.7 | |
| Dividends Paid | -32.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -304.1 | 0.0 | 0.0 | -286.7 | 1.4 | 31.3 | 0.7 | 9.6 | 0.5 | 7.1 | 7.6 | 47.6 | 67.1 | 404.9 | 448.4 | 0.0 | 0.2 | |
| Cash from Financing | -376.3 | 0.0 | 0.0 | -289.7 | -1.6 | 29.1 | -2.2 | 6.8 | -1.6 | 4.1 | -58.2 | 40.9 | 308.8 | -45.0 | 464.8 | -40.7 | -23.3 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 71.6 | -1.1 | -1.4 | -1.4 | -290.5 | -2.0 | -2.1 | 79.4 | -0.6 | -0.6 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.6 | 0.0 | |
| Repurchase of Common Stock | -31.0 | 0.0 | 0.0 | 0.0 | 0.0 | -115.6 | -85.3 | -28.3 | -2.4 | -0.8 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -32.8 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -276.5 | 2.4 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -276.5 | 1.6 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -130.6 | 828.6 | -166.3 | 165.0 | -45.1 | 64.6 | 69.2 | -63.0 | 75.5 | 4.9 | 5.3 | -43.0 | 56.5 | 13.4 | 45.2 | -40.9 | -7.6 | |
| Closing Cash Balance | 535.2 | 1,119.8 | 291.1 | 457.5 | 292.5 | 337.5 | 273.0 | 203.8 | 266.8 | 191.3 | 186.4 | 181.1 | 224.1 | 97.0 | 83.6 | 38.4 | 79.3 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 503.3 | 95.3 | 121.4 | 108.7 | -105.1 | -138.9 | 114.4 | -36.7 | -190.2 | -18.1 | |
| Closing Cash Balance | 1,119.8 | 616.4 | 521.2 | 399.8 | 291.1 | 396.3 | 535.2 | 420.8 | 457.5 | 647.7 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 327.1 | 480.3 | 405.6 | 353.3 | -17.2 | 72.7 | 40.6 | -18.9 | 29.9 | -32.1 | -107.5 | -93.2 | -22.5 | 104.3 | -19.5 | -15.3 | -28.0 | |
| Real Free Cash Flow | 224.0 | 480.3 | 309.0 | 252.4 | -111.5 | -14.9 | -49.5 | -119.8 | -75.5 | -116.0 | -201.9 | -190.6 | -82.1 | 69.6 | -48.3 | -35.1 | -42.0 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 170.1 | 84.4 | 137.2 | 88.7 | 180.6 | 73.3 | 138.9 | 12.8 | 90.2 | 85.3 | |
| Real Free Cash Flow | 242.5 | 59.7 | 112.2 | 65.9 | 159.9 | 50.8 | 138.9 | -20.0 | 64.4 | 61.3 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 19.7 | -25.8 | -1.4 |
| P/S | 3.2 | 7.5 | 9.4 |
| P/B | 2.7 | 4.3 | 5.2 |
| P/FCF | 9.9 | -244.9 | -1.5 |
| Market cap | $5.4 | $4.8 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 3.1 % | 16.7 % | 0 % |
| Debt to Income | 29.6 % | -167.4 % | 0 % |
| Debt to Free cash flow | 14.9 % | 20.1 % | 0 % |
| Interest expense percentage | 4.8 % | 2 % | 44.7 % |
| Current ratio | 3.7 | 4.2 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 13.9 % | -4.9 % | 0 % |
| ROA | 10.4 % | -3.3 % | 0 % |
| CapEx to Revenue | 3.3 % | 5.2 % | 0 % |
| RaD to Revenue | 0 % | 27.6 % | 0 % |
| ROEM | 819,943.9 | 228396.2 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 86 % | 52 % | 68.7 % |
| Operating margin | 23.6 % | -9.9 % | 35.5 % |
| Net margin | 22.3 % | -10.7 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0.3 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 168.5 mil | 149.0 mil |
| Employee count | 1.8 tis | 1.9 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
